The effect of prophylactic dexmedetomidine on hemodynamic disturbances to double-lumen endotracheal intubation: A prospective, randomized, double-blind, and placebo-controlled trial
The purpose of this study was to determine the effect of dexmedetomidine on hemodynamic responses to DLT intubation compared to placebo and to assess the adverse effects related to dexmedetomidine. Sixty patients were randomly allocated to receive 0.7 g/kg dexmedetomidine (n=30) or normal saline (n=...
محفوظ في:
المؤلفون الرئيسيون: | Pipanmekaporn T., Punjasawadwong Y., Charuluxananan S., Lapisatepun W., Bunburaphong P. |
---|---|
التنسيق: | مقال |
اللغة: | English |
منشور في: |
2014
|
الوصول للمادة أونلاين: | http://www.scopus.com/inward/record.url?eid=2-s2.0-84883198846&partnerID=40&md5=404c5230b59cfda6f62593a1334ff275 http://www.ncbi.nlm.nih.gov/pubmed/23983684 http://cmuir.cmu.ac.th/handle/6653943832/4132 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
المؤسسة: | Chiang Mai University |
اللغة: | English |
مواد مشابهة
-
The effect of prophylactic dexmedetomidine on hemodynamic disturbances to double-lumen endotracheal intubation: A prospective, randomized, double-blind, and placebo-controlled trial
بواسطة: Tanyong Pipanmekaporn, وآخرون
منشور في: (2018) -
The effect of prophylactic dexmedetomidine on hemodynamic disturbances to double-lumen endotracheal intubation: A prospective, randomized, double-blind, and placebo-controlled trial
بواسطة: Tanyong Pipanmekaporn, وآخرون
منشور في: (2018) -
The Airway Scope for difficult double-lumen tube intubation
بواسطة: Poon, K.H., وآخرون
منشور في: (2016) -
The Effectiveness of Intravenous Parecoxib on the Incidence of Ipsilateral Shoulder Pain After Thoracotomy: A Randomized, Double-Blind, Placebo-Controlled Trial
بواسطة: Tanyong Pipanmekaporn, وآخرون
منشور في: (2018) -
Lung ultrasound is non-inferior to bronchoscopy for confirmation of double-lumen endotracheal tube positioning: a randomized controlled noninferiority study
بواسطة: Sawita Kanavitoon, وآخرون
منشور في: (2022)